CG
AXNX

Carmignac Gestion’s Axonics, Inc. Common Stock AXNX Stock Holding History

Carmignac Gestion’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,928
Closed -$2.36M – 182
2024
Q3 		$2.36M Sell
33,928
-23,248
-41% -$1.59M 0.04% 110
2024
Q2 		$3.84M Sell
57,176
-32,299
-36% -$2.18M 0.07% 90
2024
Q1 		$6.17M Buy
+89,475
New +$6.04M 0.1% 65

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Carmignac Gestion's AXNX Position: Q4 2024 in Review

Carmignac Gestion sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 33,928 shares — an estimated $2.36M sold.

Carmignac Gestion first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $6.17M in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Carmignac Gestion reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Carmignac Gestion sold 33,928 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.36M.
  • Carmignac Gestion first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Carmignac Gestion's Axonics, Inc. Common Stock position peaked at $6.17M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Carmignac Gestion's 13F filing for Q4 2024, filed 13 Feb 2025.